Back, S. & Rivkees, S. 2004 Emerging concepts in
periventricular white matter injury. Semin. Perinatol. 6,
405–414. (doi:10.1053/j.semperi.2004.10.010)
Bjorklund, A. & Lindvall, O. 2000 Cell replacement therapies
for central nervous system disorders. Nat. Neurosci. 3,
537–544. (doi:10.1038/75705)
Bjorklund, L., Sanchez-Pernaute, R., Chung, S., Jenkins, B.,
Wahlestedt, C., Kim, K. M. & Isacson, O. 2002
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat
model. Proc. Natl Acad. Sci. USA 99, 2344–2349. (doi:10.
1073/pnas.022438099)
Brustle, O., Choudhary, K., Karram, K., Huttner, A.,
Murray, K., Dubois-Dalcq, M. & McKay, R. 1998
Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats.
Nat. Biotechnol. 16, 1040–1044.
Brustle, O., Jones, K. N., Learish, R. D., Karram, K.,
Choudhary, K., Wiestler, O. D., Duncan, I. D. & McKay,
R. D. 1999 Embryonic stem cell-derived glial precursors: a
source of myelinating transplants. Science 285, 754–756.
(doi:10.1126/science.285.5428.754)
Capela, A. & Temple, S. 2002 LeX/ssea-1 is expressed by
adult mouse CNS stem cells, identifying them as nonependymal. Neuron 35, 865–875. (doi:10.1016/S0896-6273(02)00835-8)
Carpenter, M., Cui, X., Hu, Z., Jackson, J., Sherman, S.,
Seiger, A. & Wahlberg, L. 1999 In vitro expansion of a
multipotent population of human neural progenitor cells.
Exp. Neurol. 158, 265–278. (doi:10.1006/exnr.1999.7098)
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. & Prasher, D.
1994 Green fluorescent protein as a marker for gene
expression. Science 263, 802–805.
Chmielnicki, E. & Goldman, S. 2005 Stem cells and cellbased therapy in neurodegenerative disease. In Neurodegenerative diseases (ed. M. F. Beal, A. Lang & A.
Ludolph), pp. 347–362. Cambridge, UK: Cambridge
University Press.
Einheber, S., Zannazi, G., Ching, W., Scherer, S., Milner, T.,
Peles, E. & Salzer, J. 1997 The axonal membrane protein
Caspr, a homologue of neurexin IV, is a component of the
septate-like paranodal junctions that assemble during
myelination. J. Cell Biol. 139, 1495–1506. (doi:10.1083/
jcb.139.6.1495)
Flax, J., Aurora, S., Yang, C., Simonin, C., Willis, A.,
Sidman, R., Wolfe, J., Kim, S. & Snyder, E. 1998
Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.
Nat. Biotechnol. 16, 1033–1039. (doi:10.1038/3473)
Follett, P., Deng, W., Dai, W., Talos, D., Massilon, L.,
Rosenberg, P., Volpe, J. & Jensen, F. 2004 Glutamate
receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
J. Neurosci. Res. 24, 4412–4420.
Franklin, R. J. M. 2002 Why does remyelination fail in
multiple sclerosis? Nat. Rev. Neurosci. 3, 705–714. (doi:10.
1038/nrn917)
Freed, C. et al. 2001 Transplantation of embryonic dopamine
neurons for severe Parkinson's disease. N. Engl. J. Med.
344, 710–719. (doi:10.1056/NEJM200103083441002)
Fricker, R., Carpenter, M., Winkler, C., Greco, C., Gates,
M. & Bjorklund, A. 1999 Site-specific migration and
neuronal differentiation of human neural progenitor cells
after transplantation in the adult rat brain. J. Neurosci. 19,
5990–6005.
Gage, F. H. 2002 Neurogenesis in the adult brain. J. Neurosci.
22, 612–613.
